Related Experiment Video
Updated: Apr 28, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer
Manoj M Pillai1, Austin E Gillen, Tomomi M Yamamoto
1Section of Hematology, Yale Cancer Center, New Haven, CT, USA.
Abstract:
miRNAs regulate the expression of genes in both normal physiology and disease. While miRNAs have been demonstrated to play a pivotal role in aspects of cancer biology, these reports have generally focused on the regulation of single genes. Such single-gene approaches have significant limitations, relying on miRNA expression levels and heuristic predictions of mRNA-binding sites. This results in only circumstantial evidence of miRNA-target interaction and typically leads to large numbers of false positive predictions. Here, we used a genome-wide approach (high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation, HITS-CLIP) to define direct miRNA-mRNA interactions in three breast cancer subtypes (estrogen receptor positive, Her2 amplified, and triple negative). Focusing on steroid receptor signaling, we identified two novel regulators of the ER pathway (miR-9-5p and miR-193a/b-3p), which together target multiple genes involved in ER signaling. Moreover, this approach enabled the definition of miR-9-5p as a global regulator of steroid receptor signaling in breast cancer. We show that miRNA targets and networks defined by HITS-CLIP under physiologic conditions are predictive of patient outcomes and provide global insight into miRNA regulation in breast cancer.
Insights
This study reveals novel microRNA (miRNA) regulators of breast cancer, identifying specific miRNAs that target multiple genes in estrogen receptor signaling. These findings offer a global view of miRNA regulation in breast cancer subtypes.
Area of Science:
- Genomics
- Molecular Biology
- Oncology
Background:
- MicroRNAs (miRNAs) are key gene regulators in health and disease.
- Previous studies on miRNAs in cancer often used limited single-gene approaches, leading to potential inaccuracies.
- Direct miRNA-mRNA interactions in breast cancer remain incompletely understood.
Purpose of the Study:
- To identify direct miRNA-mRNA interactions across different breast cancer subtypes using a genome-wide approach.
- To uncover novel miRNA regulators involved in steroid receptor signaling pathways.
- To assess the predictive value of miRNA-target networks for patient outcomes.
Main Methods:
- High-throughput sequencing of RNA isolated by crosslinking immunoprecipitation (HITS-CLIP) was employed.
- Genome-wide analysis was performed on three breast cancer subtypes: estrogen receptor positive, Her2 amplified, and triple negative.
- Focus was placed on steroid receptor signaling pathways.
Main Results:
- Direct miRNA-mRNA interactions were defined genome-wide.
- Two novel regulators of the estrogen receptor (ER) pathway, miR-9-5p and miR-193a/b-3p, were identified.
- miR-9-5p was characterized as a global regulator of steroid receptor signaling in breast cancer.
Conclusions:
- HITS-CLIP provides a robust method for defining direct miRNA-mRNA interactions, overcoming limitations of previous methods.
- The identified miRNA-target networks offer global insights into miRNA regulation in breast cancer.
- Defined miRNA networks are predictive of patient outcomes, highlighting their clinical relevance.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Co-activators and Co-repressors
Master Transcription Regulators
Signal Transduction: Overview
Typically, signal transduction involves three...
Negative Regulator Molecules

